Moleculin Biotech, Inc. (39) | Sales Agreements (2)
- At Market Issuance Sales Agreement, dated July 17, 2020, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 17, 2020)
- At Market Issuance Sales Agreement, dated July 23, 2019, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 24, 2019)
